Group CEO Tony Veverka says 'The BioEden technique can offer many advantages over the known stem cell storage from umbilical cord blood. Moreover, the method is simpler and more affordable',
(PRWEB UK) 16 December 2015
More and more parents are choosing to cyropreserve the stem cells from their children's naturally shed baby teeth as BioEden announce further expansion and 'go Dutch'.
Stem cell therapy and research shows no sign of slowing down as BioEden announce a record breaking 275% demand for their service, and extend their reach to Belgium and Holland.
BioEden was originally founded in 2006 in Austin Texas and was the first specialist stem cell bank, today widely acknowledged as the market leader. The company stores stem cells from the baby teeth of children, and emphasises that there is no need for the teeth to be extracted, as they fall out naturally.
The BioEden method of stem cell isolation and storage of baby teeth is unique and holds the only issued patent. With members in more than 60 countries and laboratories in Asia, the United States and the United Kingdom BioEden continues to lead and develop their proposition, which could bring stem cell banking to the masses.
Group CEO Tony Veverka says 'The BioEden technique can offer many advantages over the known stem cell storage from umbilical cord blood. Moreover, the method is simpler an more affordable.
We are delighted to be able to provide our potentially life saving services to the people of Belgium and Holland'